Wedbush Securities’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$960K Sell
2,467
-153
-6% -$59.5K 0.03% 425
2025
Q1
$1.14M Buy
2,620
+8
+0.3% +$3.48K 0.04% 356
2024
Q4
$963K Sell
2,612
-384
-13% -$142K 0.03% 387
2024
Q3
$1.56M Sell
2,996
-835
-22% -$434K 0.06% 243
2024
Q2
$2.08M Sell
3,831
-22
-0.6% -$11.9K 0.07% 189
2024
Q1
$2M Buy
3,853
+573
+17% +$297K 0.07% 209
2023
Q4
$1.55M Sell
3,280
-114
-3% -$53.8K 0.07% 213
2023
Q3
$1.48M Sell
3,394
-175
-5% -$76.2K 0.07% 205
2023
Q2
$1.59M Buy
3,569
+151
+4% +$67.1K 0.08% 201
2023
Q1
$1.57M Sell
3,418
-115
-3% -$52.9K 0.08% 198
2022
Q4
$1.81M Sell
3,533
-498
-12% -$255K 0.1% 166
2022
Q3
$1.83M Buy
4,031
+1,469
+57% +$667K 0.1% 154
2022
Q2
$1.24M Buy
2,562
+14
+0.5% +$6.75K 0.07% 244
2022
Q1
$1.25M Sell
2,548
-379
-13% -$186K 0.06% 285
2021
Q4
$1.36M Sell
2,927
-606
-17% -$281K 0.06% 284
2021
Q3
$1.32M Sell
3,533
-108
-3% -$40.3K 0.06% 289
2021
Q2
$1.39M Buy
3,641
+83
+2% +$31.7K 0.07% 276
2021
Q1
$1.28M Buy
+3,558
New +$1.28M 0.07% 267
2020
Q4
Sell
-3,230
Closed -$867K 902
2020
Q3
$867K Sell
3,230
-69
-2% -$18.5K 0.08% 247
2020
Q2
$867K Buy
3,299
+466
+16% +$122K 0.08% 250
2020
Q1
$643K Buy
2,833
+327
+13% +$74.2K 0.08% 287
2019
Q4
$757K Buy
2,506
+277
+12% +$83.7K 0.07% 332
2019
Q3
$535K Buy
2,229
+119
+6% +$28.6K 0.05% 420
2019
Q2
$595K Buy
2,110
+285
+16% +$80.4K 0.06% 367
2019
Q1
$524K Sell
1,825
-36
-2% -$10.3K 0.06% 390
2018
Q4
$489K Sell
1,861
-137
-7% -$36K 0.06% 360
2018
Q3
$548K Buy
1,998
+167
+9% +$45.8K 0.06% 364
2018
Q2
$436K Buy
1,831
+652
+55% +$155K 0.05% 419
2018
Q1
$259K Buy
+1,179
New +$259K 0.03% 585